Biotage AB (BIOT.ST)

BIOT.ST on Stockholm Stock Exchange

18.00SEK
7:28am EDT
Change (% chg)

0.50kr (+2.86%)
Prev Close
17.50kr
Open
17.50kr
Day's High
18.00kr
Day's Low
17.50kr
Volume
40,124
Avg. Vol
46,042
52-wk High
19.30kr
52-wk Low
10.45kr

BIOT.ST

Chart for BIOT.ST

About

Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical... (more)
No analyst recommendations are available for BIOT.ST.

Overall

Beta: 0.96
Market Cap(Mil.): kr1,132.50
Shares Outstanding(Mil.): 64.71
Dividend: 0.75
Yield (%): 4.29

Financials

  BIOT.ST Industry Sector
P/E (TTM): 18.29 37.13 35.59
EPS (TTM): 0.96 -- --
ROI: 12.47 11.83 14.96
ROE: 12.89 13.91 15.84
Search Stocks

BRIEF-Biotage Q2 operating profit rises

* Says group net sales in Q2 2015 amounted to 148.1 msek (120.4)

13 Aug 2015

BRIEF-Biotage says launches share buy-back

* Says shares acquired may not exceed 10 percent of the total number of outstanding Biotage shares at any time Source text for Eikon: Further company coverage:

29 Apr 2015

BRIEF-Biotage Q1 operating profit dubbed as U.S. business grow

* Says Q1 net sales 144.2 million SEK (113.7), an increase by 26.8 percent

28 Apr 2015

BRIEF-Biotage scraps one of three financial targets

* Says now have two financial goals in its business, an organic growth goal of 8 Percent and an EBIT goal of 10 percent

26 Mar 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Sadif Analytics Prime
$25.00
Provider : GlobalData
$125.00
Provider : GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks